Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab

NCT01135641 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01135641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01135641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
March 31, 2014
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease